LinkinVAX Completes First Batch Production of “PanCov”, Its Next Generation Multi-variant Vaccine Against Covid and Other Coronaviruses
PARIS & TOULOUSE, France--(BUSINESS WIRE)--Jul 20, 2023--LinKinVax, a clinical-stage biotechnology company, announced the manufacture and bottling of a GMP batch of its next generation pan-sarbecovirus vaccines, known as <em>PanCov</em>, designed to ...